Accession Number: | 0001209191-21-067999 |
Date: | 2021-12-01 |
Issuer: | PULMONX CORP (LUNG) |
Original Submission Date: |
FRENCH GLENDON E. III
C/O PULMONX CORPORATION
700 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-12-01 | S | 1,421 | d | $32.73 | 1,138,949 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | these shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on june 1, 2021. |